Edition:
United States

Transgene SA (TRNG.PA)

TRNG.PA on Paris Stock Exchange

2.76EUR
5:57am EDT
Change (% chg)

€-0.00 (-0.18%)
Prev Close
€2.77
Open
€2.82
Day's High
€2.82
Day's Low
€2.76
Volume
8,996
Avg. Vol
56,777
52-wk High
€3.60
52-wk Low
€2.40

Select another date:

Thu, Apr 26 2018

BRIEF-Transgene Q1 Operating Revenue Stable At 1.8 Million Euros

* TRANSGENE: €35.6 MILLION IN CASH AND CASH EQUIVALENTS AS OF MARCH 31, 2018

BRIEF-Transgene Says PCPV Most Promising Therapeutic Candidate Amongst Evaluated Poxviridae

* PCPV WAS FOUND TO BE MOST PROMISING THERAPEUTIC CANDIDATE AMONGST POXVIRIDAE EVALUATED BY TRANSGENE Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Select another date: